Encompass Health reports results for fourth quarter 2019 and reiterates full-year 2020 guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Encompass Health Corporation (EHC) Tops Q4 EPS by 1c, Offers Guidance
February 6, 2020 4:27 PM ESTEncompass Health Corporation (NYSE: EHC) reported Q4 EPS of $0.85, $0.01 better than the analyst estimate of $0.84. Revenue for the quarter came in at $1.18 billion versus the consensus estimate of $1.18 billion.
GUIDANCE:
Encompass Health Corporation sees FY2020 EPS of $3.50-$3.72, versus the consensus... More
